Panagora Asset Management Inc Sangamo Therapeutics, Inc Transaction History

Panagora Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $655,819 - $1.24 Million	-199,945 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$5.23 - $7.82 $2.1 Million - $3.14 Million	-401,576 Reduced 66.76%	199,945 $1.16 Million
Q4 2021 Feb 10, 2022	SELL	$7.29 - $10.97 $66,113 - $99,486	-9,069 Reduced 1.49%	601,521 $4.51 Million
Q3 2021 Nov 10, 2021	BUY	$9.01 - $12.01 $42,283 - $56,362	4,693 Added 0.77%	610,590 $5.5 Million
Q2 2021 Aug 11, 2021	SELL	$10.17 - $12.64 $301,754 - $375,041	-29,671 Reduced 4.67%	605,897 $7.25 Million
Q1 2021 May 12, 2021	SELL	$10.88 - $17.05 $184,557 - $289,219	-16,963 Reduced 2.6%	635,568 $7.96 Million
Q4 2020 Feb 10, 2021	BUY	$9.23 - $18.18 $1.55 Million - $3.04 Million	167,489 Added 34.53%	652,531 $10.2 Million
Q3 2020 Nov 13, 2020	BUY	$9.38 - $12.48 $168,417 - $224,078	17,955 Added 3.84%	485,042 $4.58 Million
Q2 2020 Aug 12, 2020	BUY	$6.21 - $11.83 $647,864 - $1.23 Million	104,326 Added 28.76%	467,087 $4.19 Million
Q1 2020 May 14, 2020	BUY	$5.05 - $8.85 $983,527 - $1.72 Million	194,758 Added 115.93%	362,761 $2.31 Million
Q4 2019 Feb 12, 2020	BUY	$8.03 - $11.7 $1.35 Million - $1.97 Million	168,003 New	168,003 $1.41 Million

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.